Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

By sjmartinez • February 22, 2024

Lu MT, Ribaudo H, Foldyna B, Zanni MV, Mayrhofer T, Karady J, Taron J, Fitch KV, McCallum S, Burdo TH, Paradis K, Hedgire SS, Meyersohn NM, DeFilippi C, Malvestutto CD, Sturniolo A, Diggs M, Siminski S, Bloomfield GS, Alston-Smith B, Desvigne-Nickens P, Overton ET, Currier JS, Aberg JA, Fichtenbaum CJ, Hoffmann U, Douglas PS, Grinspoon SK; REPRIEVE Trial Writing Group. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial. JAMA Cardiol. 2024 Feb 21. doi: 10.1001/jamacardio.2023.5661. Epub ahead of print. PMID: 38381407.

Tags: Infectious Diseases, Publications

Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series

Ito Y, Hoeltermann TA, Anjum S, Robinson L, Little JS, Kiritsy M, Steinbrink JM, Finocchi A, Walker LW, Avery RK, Shoham S, Beaird OE, Ong[...]

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

Doni Jayavelu N, Samaha H, Wimalasena ST, Hoch A, Gygi JP, Gabernet G, Ozonoff A, Liu S, Milliren CE, Levy O, Baden LR, Melamed E,[...]

Can chlorhexidine bathing reduce Candidozyma auris shedding?

Gussin GM, Singh RD, Kleinman K, Saavedra R, Shimabukuro JA, Flores EA, Miller LG, Bittencourt CE, Huang SS. Can chlorhexidine bathing reduce Candidozyma auris shedding?[...]